Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International Journal of Molecular Sciences 2015, 16, 14951-14960. DOI: 10.3390/ijms160714951
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2018
- Creator
-
Kolb-Mäurer, Annette
Goebeler, Matthias
Mäurer, Mathias
- URN
-
urn:nbn:de:bvb:20-opus-148451
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kolb-Mäurer, Annette
- Goebeler, Matthias
- Mäurer, Mathias
- Universität Würzburg
Time of origin
- 2018
Other Objects (12)
Unraveling the mechanisms of EGFR-inhibitor associated cutaneous adverse effects.
Adverse cutaneous drug eruptions : 34 tables
Type I Interferon Induction in Cutaneous DNA Damage Syndromes
Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis
Multiple sclerosis relapses are not associated with exercise
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis : results from the European Interferon‑beta Pregnancy Registry
Fatigue in Multiple Sclerosis Is Associated With Childhood Adversities
Cutaneous lupus erythematosus
Cutaneous facial surgery
Unraveling the mechanisms of EGFR-inhibitor associated cutaneous adverse effects.
Adverse cutaneous drug eruptions : 34 tables
Type I Interferon Induction in Cutaneous DNA Damage Syndromes
Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis
Multiple sclerosis relapses are not associated with exercise
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis : results from the European Interferon‑beta Pregnancy Registry
Fatigue in Multiple Sclerosis Is Associated With Childhood Adversities
Cutaneous lupus erythematosus
Cutaneous facial surgery
Unraveling the mechanisms of EGFR-inhibitor associated cutaneous adverse effects.
Adverse cutaneous drug eruptions : 34 tables
Type I Interferon Induction in Cutaneous DNA Damage Syndromes
Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis
Multiple sclerosis relapses are not associated with exercise
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis : results from the European Interferon‑beta Pregnancy Registry
Fatigue in Multiple Sclerosis Is Associated With Childhood Adversities
Cutaneous lupus erythematosus